Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.8.0.1
Document and Entity Information - shares
3 Months Ended
Mar. 31, 2018
May 15, 2018
Document and Entity Information [Abstract]    
Entity Registrant Name CONVERSION LABS, INC.  
Entity Central Index Key 0000948320  
Trading Symbol IMMD  
Amendment Flag true  
Amendment Description

This Amendment No. 1 on Form 10-Q/A (the “Amendment”) amends Conversion Labs, Inc.’s (formerly known as ImmuDyne, Inc.) Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2018 (the “Form 10-Q”), as filed with the Securities and Exchange Commission on May 15, 2018, and is being filed solely to correct a mathematical error in the comparable balance sheet as of December 31, 2017, which caused a change to the statement of cash flows for the first quarter of 2018. Pursuant to Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended, we have repeated the entire text of Item 1 of the Form 10-Q in this Amendment. This Amendment includes new certifications by our Principal Executive Officer and Principal Financial Officer pursuant to Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 attached as Exhibits 31.1, 31.2, 32.1 and 32.2 hereto.

 

Except as expressly set forth above, this Amendment does not, and does not purport to, amend, update or restate the information in any other item of the Form 10-Q or reflect any events that have occurred after the filing of the Form 10-Q.

 
Current Fiscal Year End Date --12-31  
Document Type 10-Q  
Document Period End Date Mar. 31, 2018  
Document Fiscal Year Focus 2018  
Document Fiscal Period Focus Q1  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   43,257,342